Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes [Phase 2]
A Phase 2 trial comparing different doses of NN0519-0130 for lowering blood sugar in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Maridebart Cafraglutide in adults with Type 2 Diabetes Mellitus who are obese or overwei…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Research Study of a New Medicine NNC0113-6856 in Healthy Males [Phase 1]
Phase 1 clinical trial update reports the completion of Novo Nordisk's NNC0113-6856 in healthy male volunteers. The study lists Type 2 Diabe…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes [Phase 1]
This completed Phase 1 trial assesses the safety and preliminary effects of the experimental drug NNC0519 0130 in adults with obesity, with …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
This ClinicalTrials.gov post-marketing surveillance study assesses long-term safety data for Ozempic (semaglutide) in adults with type 2 dia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes. [Phase 1]
Phase 1 study of the investigational medicine NNC0519-0130 by Novo Nordisk has completed, enrolling healthy volunteers, overweight individua…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
This clinical trial update describes a follow-up study examining MASLD in adults with Type 2 diabetes in primary care, with enrollment by in…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: GOAL: A Research Study Looking at Long Term Blood Sugar Control in People With Type 2 Diabetes Treated With Xultophy® in Local Clinical Practice in Japan.
A completed clinical trial in Japan evaluating long-term blood sugar control in people with Type 2 diabetes treated with Xultophy (insulin d…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES) [NA]
This clinical trial update reports ongoing recruitment for BARIAKINES, a study aiming to identify human biomarkers predictive of diabetes re…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Post-marketing surveillance study in Korea to evaluate the safety and effectiveness of Xultophy (insulin degludec/liraglutide) in adults wit…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI) [Phase 4]
A Phase 4 clinical trial comparing the effectiveness, safety, and cost-effectiveness of dapagliflozin versus empagliflozin in adults with ty…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Connected Care for Type 2 Diabetes Self-Management [NA]
A clinical trial coordinated by the Marche Region Regional Health Agency is recruiting to evaluate connected care for self-management in Typ…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effect of Narrative Education on Glycemic Control in Adults With Type 2 Diabetes in Primary Care [NA]
This clinical trial will assess whether narrative education improves glycemic control in adults with Type 2 diabetes managed in primary care…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
This recruiting trial evaluates the clinical, morphometric, and biochemical effects of GLP-1 receptor agonists on adiposopathy in people wit…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Mediterranean Diet vs DASH and MIND in T2DM
A completed clinical trial comparing Mediterranean diet, DASH diet, and MIND diet in people with Type 2 Diabetes. The update does not provid…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Real World Effectiveness of Oral Semaglutide in Thailand Participants With Type 2 Diabetes
A real-world study from Thailand assessing the effectiveness of oral semaglutide in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity
A completed clinical trial evaluating the relationship between continuous glucose monitoring metrics in pregnant people with type 2 diabetes…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships [NA]
A clinical trial at Boston Medical Center aims to improve Type 2 diabetes care by addressing health-related social needs and building commun…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
A completed clinical study examining how oral semaglutide behaves in people with Type 2 diabetes in Finland as part of local clinical practi…
-
CLINICAL_TRIALS other · 2025-12-30Clinical Trial Update: Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin. [NA]
This clinical trial compares real-time continuous glucose monitoring with intermittent monitoring in insulin-treated Type 2 diabetes patient…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of HTD1801, a berberine-ursodeoxycholate formulation, in adults with Type 2 Diabet…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes [Phase 2]
This document announces the completion of a Phase 2 clinical trial evaluating various doses of NNC0487-0111 to lower blood sugar in adults w…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone [Phase 3]
This clinical trial update describes a Phase 3 bridge study to evaluate the efficacy and safety of IN-B00009 injections in adults with Type …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Precision Diabetes Management: Integrated East-West Approach
This entry provides details of a clinical trial exploring a precision diabetes management approach that integrates East-West strategies for …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents [Phase 4]
A Phase 4 clinical trial in China assessing the efficacy and safety of iGlarLixi versus standard of care in adults with uncontrolled Type 2 …